Valeant Pharmaceuticals International IncVRX:TOR

126.60
0.10 / 0.08%
193.02k
23.39%
0.7304
Close in CADToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Aug 28 2014 21:00 BST.

Summary

On Thursday, Valeant Pharmaceuticals International Inc (VRX:TOR) closed at 126.60, 26.73% above the 52 week low of 99.90 set on Aug 28, 2013.

52-week range
Today
99.90
Aug 28 2013
170.45
Feb 27 2014
Markit short selling activity
Low
Medium
High
Open126.70
Day high127.35
Day low125.95
Bid126.24
Offer127.41
Previous close126.70
Average volume246.73k
Shares outstanding333.57m
Free float325.74m
P/E (TTM)--
Market cap42.26bn CAD
EPS (TTM)-2.4399 CAD
Data delayed at least 15 minutes, as of Aug 28 2014 21:00 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Valeant Pharmaceuticals International Inc+1.65%-5.65%-23.25%+23.39%+808.83%
TSX-Toronto Stock Exchange 300 Compo+0.01%+0.73%+9.45%+23.41%+41.72%
CA/HEALTH CARE+1.00%-3.63%-19.24%+12.40%--
CA/PHARMACEUTICALS+1.63%-5.99%-24.85%+18.96%--
Data delayed at least 15 minutes, as of Aug 28 2014 21:00 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.